Ads
related to: acute hepatitis c treatment guidelines- FAQs About Hepatitis C
Get The Facts About Hepatitis C &
Read About A Treatment Option Today
- A Hep C Treatment Regimen
Ready To Treat Your Hep C?
Learn About A Treatment Option Here
- What Is Hepatitis C
Learn About Hepatitis C & Discover
A Hep C Treatment Option Here.
- Risks Of Hepatitis C
Read About The Risks Of Hep C And
Explore A Hep C Treatment Here.
- Find A Hep C Provider
Ready To Take The Next Step? Find
A Hep C Provider Near You Today!
- Download A Co-Pay Coupon
Eligible Patients May Pay As Little
As $5 Per Co-Pay For A Treatment
- FAQs About Hepatitis C
Search results
Results From The WOW.Com Content Network
Hepatitis C is an infectious disease caused by the hepatitis C virus (HCV) that primarily affects the liver; [2] it is a type of viral hepatitis. [6] During the initial infection period, people often have mild or no symptoms. [ 1 ]
Hepatitis C treatment guidelines also vary based on whether you have cirrhosis (scarring of the liver) and how severe it is. Related: 15 Celebrities With Hepatitis C, from Natasha Lyonne to David ...
Acute hepatitis C occurs within the first 6 months after someone is exposed to the hepatitis C virus. Hepatitis C can be a short-term illness, but for most people, acute infection leads to chronic ...
Acute hepatitis C refers to the first six months of the viral infection. ... almost 100 percent of people can be free of hepatitis C,” says Dr. Menon. The exact treatment you receive will depend ...
The hepatitis C virus (HCV) [3] is a small (55–65 nm in size), enveloped, positive-sense single-stranded RNA virus of the family Flaviviridae. The hepatitis C virus is the cause of hepatitis C and some cancers such as liver cancer (hepatocellular carcinoma, abbreviated HCC) and lymphomas in humans. [4] [5]
Ledipasvir/sofosbuvir, sold under the trade name Harvoni among others, is a medication used to treat hepatitis C. [8] It is a fixed-dose combination of ledipasvir and sofosbuvir. [8] Cure rates are 94% to 99% in people infected with hepatitis C virus (HCV) genotype 1. [9] Some evidence also supports use in HCV genotype 3 and 4. [9]
Ads
related to: acute hepatitis c treatment guidelines